Recently, I have been researching various AI video tools, starting with Seedance.Which AI video model moves the best? How ...
Isamu Noguchi never liked to play by the rules. So when the Japanese-American artist was invited to represent the United States at the 1986 Venice Biennale, he was hardly phased by the barrage of mail ...
Akari's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Akari's pipeline includes a Phase 3 clinical trial ...
BOSTON and LONDON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, ...
Akari Therapeutics (NASDAQ:AKTX) shares traded higher in the morning hours on Wednesday as the company announced a portfolio prioritization plan alongside new appointments to key management positions.
On Thursday, Akari Therapeutics said it filed a new PCT application covering its PH1 payload and its ability to disrupt multiple cancer-driving pathways through RNA splicing modul ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results